Related Experiment Video
Updated: Nov 12, 2025

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Impact of Bypass Flow Assessment on Long-Term Outcomes in Patients with Chronic Limb-Threatening Ischemia
Ilijas Cinara1, Petar Zlatanovic2, Milos Sladojevic1,3
1Clinic for Vascular and Endovascular Surgery, Clinical Center of Serbia, Dr Koste Todorovica 8, 11000, Belgrade, Serbia.
Insights
Transit time flow measurement (TTFM) helps assess bypass grafts in chronic limb-threatening ischemia (CLTI) patients. Low graft flow (mean <100ml/min, diastolic <40ml/min) significantly increases adverse limb events and reduces graft patency.
Area of Science:
- Vascular Surgery
- Medical Devices
- Clinical Outcomes Research
Background:
- Chronic limb-threatening ischemia (CLTI) necessitates complex surgical interventions.
- Below-the-knee (BTK) vein bypass surgery is a critical treatment for CLTI.
- Intraoperative graft assessment is vital for long-term success.
Purpose of the Study:
- To evaluate the impact of graft flow measurements on long-term clinical outcomes.
- To determine the prognostic value of transit time flow meter (TTFM) parameters in BTK vein bypass surgery for CLTI patients.
- To identify specific TTFM thresholds associated with adverse outcomes.
Main Methods:
- Retrospective analysis of 249 CLTI patients undergoing BTK vein bypass surgery.
- Graft flow assessed using TTFM at the end of the procedure.
- Patients categorized into four groups based on mean (<100 ml/min) and diastolic (<40 ml/min) graft flow.
- Primary endpoints: major adverse limb event (MALE) and primary graft patency.
Main Results:
- A subgroup with mean graft flow <100 ml/min and diastolic graft flow <40 ml/min exhibited the highest MALE rates.
- The same subgroup demonstrated the poorest primary graft patency.
- Statistical significance was confirmed for both MALE and graft patency outcomes (P < 0.01).
Conclusions:
- TTFM-derived graft flow parameters are significant predictors of long-term outcomes in CLTI patients undergoing BTK bypass.
- Mean graft flow <100 ml/min combined with diastolic graft flow <40 ml/min indicates a high risk for poor graft function and limb events.
- These findings underscore the importance of intraoperative TTFM assessment for optimizing surgical strategy and patient management.
Background:
Transit time flow meter (TTFM) allows quick and accurate intraoperative graft assessment. The main study goal is to evaluate the influence of graft flow measurements on long-term clinical outcomes in patients with chronic limb-threatening ischemia (CLTI) undergoing bellow the knee (BTK) vein bypass surgery.
Methods:
Between January 1st, 1999 and January 1st, 2006, 976 CLTI consecutive patients underwent lower extremity bypass surgery. When applying the exclusion criteria, 249 patients were included in the final analysis. Control measurements were performed at the end of the procedure. Patients were divided according to the mean (more/less than 100 ml/min) and diastolic graft flow (more/less than 40 ml/min) values in four groups. The primary endpoints were a major adverse limb event (male) and primary graft patency.
Results:
After the median follow-up of 68 months, a group with the mean graft flow below 100 ml/min and the diastolic graft flow below 40 ml/min had the highest rates of male (χ2 = 36.60, DF = 1, P < 0.01, log-rank test) and the worst primary graft patency (χ2 = 53.05, DF = 1, P < 0.01, log-rank test).
Conclusion:
In patients with CLTI undergoing BTK vein bypass surgery, TTFM parameters, especially combined impact of mean graft flow less than 100 ml/min and diastolic graft flow less than 40 ml/min, were associated with an increased risk of poor long-term male and primary graft patency.
More Related Videos
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management

